Anxiety is a prevalent and serious mental health disorder affecting millions of Americans. According to the National Institute of Mental Health, almost one-third of adults will experience an anxiety disorder at some point in their lives. For those with anxiety disorders, the symptoms can be debilitating, interfering with daily activities such as work and relationships.
TruBrain, a cognitive healthcare company, recently launched a new wearable technology aimed at tackling anxiety. Designed by Ph.D. neuroscientists and notable European industrial designers, the smart wearable uses established technology that has been cleared by the Food and Drug Administration (FDA) to send safe, micro-electric currents to key parts of the brain, increasing blood flow and promoting calm. With a market size of $11 billion, TruBrain’s launch of this innovative product is a significant development in the field of cognitive healthcare.
To stay updated with top startup news and investments, sign up for Benzinga’s Startup Investing & Equity Crowdfunding Newsletter
TruBrain CEO Chris Thompson said, “Our mission is to empower people to do their best thinking. The problems we’re trying to solve are stress and anxiety. That will clear the runway for you to focus more, relax and get better sleep.”
The wearable technology is backed by thousands of scientific studies and decades of research, providing neurostimulation that can produce results in as little as 30 minutes.
TruBrain’s success as a profitable brand is evident, with over $20 million in lifetime sales and a distribution network of grassroots investors. The company’s personalized drinks package, developed by a team of University of California neuroscientists, is also a popular product.
The startup launched on StartEngine, a popular startup investing platform, and has since grown to one of the largest campaigns by amount raised on the site. The success comes after a number of notable events in the industry. For example, Elon Musk-backed Neuralink has received approval to test its devices on humans, and received hundreds of millions in investments to do it. Similarly, Amazon.com, Inc. founder Jeff Bezos and Microsoft Corp. founder Bill Gates invested in Neuralink competitor Synchron.
With its innovative wearable technology and science-backed personalized drinks package, TruBrain is well on its way to becoming the leading cognitive healthcare brand, empowering people to achieve their best thinking and live their best lives.
See more on startup investing from Benzinga.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
